Here we showed that WNT2, WNT4, and WNT16 are overexpressed in leiomyomas, and that this upregulation was more pronounced in MED12-mutated leiomyomas compared to MED12 mutation-negative specimens, which is in line with previous reports [17,19,84]. This evidence concerns the gene WNT16 and leiomyoma.